Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R)

Synonyms: MSTT 1041A

Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. It has the potential for chronic obstructive pulmonary disease (COPD), asthama treatment. MW :145.5 KD

Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.66mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. It has the potential for chronic obstructive pulmonary disease (COPD), asthama treatment. MW :145.5 KD

Product Details

CAS No. 2173054-79-8
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) | Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) supplier | purchase Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) | Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) cost | Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) manufacturer | order Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) | Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) distributor